All News

AURA-LV Trial - Voclosporin Effective in Lupus Nephritis

d Jack Cush, MD

The AURA-LV trial assessed voclosporin, a calcineurin inhibitor in patients with active lupus nephritis (LN) and found that low-dose voclosporin may be successfully added to mycophenolate mofetil and corticosteroids to controll active LN.

Read Article
WIR.large_.jpg (keep)

The RheumNow Podcast – Heartbreak of Methotrexate (11.16.18)

d Jack Cush, MD

Dr. Jack Cush reviews the news from the past week at RheumNow.com.

Read Article
tick.jpg

Growing Tick Population Comes with Health Concerns

d Jack Cush, MD

CNN has published a recent government report from the Tick-Borne Disease Working Group that suggests the US tick population is growing and may bring with it an increase in tick-related illnesses. 

Read Article
sony%20pics%20027.jpg

Pilot Data on Rituximab in Henoch-Schonlein Purpura

d Jack Cush, MD

Management of Henoch-Schonlein purpura (HSP) can be challenging as supportive care and avoidance of corticosteroids are often insufficient options. A new series of case reports and literature review of steroid refractory HSP suggests that rituximab may be effective in reducing hospital admissions, overall steroid use, and is capable of inducing remission.

Read Article
sclerodact.jpg

Scleroderma Expert Treatment Preferences

d Jack Cush, MD

Frustration may be the word that best characterizes many scleroderma management plans - owing to a lack of trials, lack of agreement and lack of clear guidance on management.

Read Article
mosquito.jpg

Chikungunya Virus Vaccine Developed

d Jack Cush, MD

Lancet reports on a new vaccine for Chikungunya fever (MV-CHIK) demonstraing excellent safety, tolerability and good immunogenicity, independent of pre-existing immunity against the vector. MV-CHIK is a promising vaccine for the prevention of chikungunya fever.

Read Article
heart-attack.jpg

Subclinical Heart Inflammation Seen in RA

d RheumNow

Subclinical myocardial inflammation is common among patients with rheumatoid arthritis (RA) and is associated with articular disease activity, researchers reported.

Read Article
80 overweight & obese pts w/ mild to moderate Knee OA Rx in RDBPCT showing garlic 1000 mg/D significantly lowers pain scores, resistin levels (but not TNF). Garlic may work by effects on MMPs, cytokines? shown to lower CRP levels https://t.co/bg5nwzUpJe https://t.co/us0uBLdCau

Links:

Dr. John Cush RheumNow ( View Tweet)

The RheumNow Podcast is up! THe Heartbreak of CIRT & MTX. view it https://t.co/jTQUFWJkNJ or listen to the Podcast on iTunes or here https://t.co/2w0vNA7VmY

Links:

Dr. John Cush RheumNow ( View Tweet)

RheumNow is featuring "Therapeutic Update: Biosimilars in Rheumatology" with video insights from several experts, including Drs. Jonathan Kay, Vibeke Strand, Lee Simon and others. Sponsored by Sandoz, Inc.; now available on RheumNow https://t.co/1vmnEJqOSi

Links:

Dr. John Cush RheumNow ( View Tweet)

I just woke. Ok if I get there around 835?

Dr. John Cush RheumNow ( View Tweet)

44 WF w/ RA is on max dose MTX + ETN for 7 mos. but still has 5 swollen joints, CDAI =13 & nl ESR/CRP. What do you do next?

Dr. John Cush RheumNow ( View Tweet)

Rapid release Tylenol gelcaps are slower to dissolve than cheaper tablets https://t.co/NBBDnl2SEt

Links:

Dr. John Cush RheumNow ( View Tweet)

Our brief year in review video on #biosimilars for @RheumNow at #ACR18: my hope is for interchangeability pathway to become final ASAP w 3 switch studies to push the marketplace so patient costs drop & access to treatment rises! https://t.co/WrK7UBOeNq

Links:

Angus Worthing MD AngusWorthing ( View Tweet)

Teaching 5th graders about the wonders of rheumatology and hoping to help with the inevitable national shortage of rheum professionals #GATI https://t.co/w8vkGpM4zf
Julio Gonzalez japaoli19 ( View Tweet)
The definition of POLYPHARMACY? Mine is when the med list requires 2 pages or when the patient cannot remember Rx names/dose due to #Drugs. Another is "many different medicines used concurrently to treat a single disease or coexisting diseases." Polypharmacy comes with high Risk

Dr. John Cush RheumNow ( View Tweet)

CCP+ RA patient starts out with 8 tender, 6 swollen and DAS=5.1. Put on MTX and TNFi and quickly goes into remission (0 joints) at month 6, 12, 18. At next visit what do you do w/ meds?

Dr. John Cush RheumNow ( View Tweet)

Matching the Reference Product is one of nine educational videos available in the "Therapeutic Update: Biosimilars in Rheumatology" video series, sponsored by Sandoz, Inc. and available on RheumNow. https://t.co/1vmnEJqOSi https://t.co/mQOWBZwuLc

Links:

Dr. John Cush RheumNow ( View Tweet)
Analysis of disease activity in 354 patients with ANCA associated vasculitis (AAV) enrolled in 4 trials shows 13% with ESRD and 19% died. Disease activity at 3 & 6 mos predicted later ESRD or death https://t.co/NZu1kJuFF2

Links:

Dr. John Cush RheumNow ( View Tweet)

Large database study of incident gout (n = 41,446) shows chronic kidney dz (CKD stage ≥ 3) was nearly doubled in gout patients (adj HR 1.78 95% CI 1.70, 1.85) and that urate lowering therapy lowered CKD risk by 40% (HR 1.31) https://t.co/5kM1TigSIf

Links:

Dr. John Cush RheumNow ( View Tweet)

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×